본문 바로가기
KERD
논문KCI 등재

간세포암종에 대한 간절제술 후 조기재발에 영향을 미치는 위험인자

Risk factors for early recurrence after surgical resection for hepatocellular carcinoma

김용훈|임태진|강구정|박의준
대한간학회 (The korean Association for the Study of the Liver)|2008.09|Clinical and Molecular Hepatology|제14권 제3호|pp. 371-380

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

위험인자재발Carcinoma간세포암종간절제술

초록

Background/Aims: Early recurrence (ER) after liver resection is one of the most important factors impacting the prognosis and survival of patients with hepatocellular carcinoma (HCC). This study aimed to identify the factors associated with ER after curative hepatic resection for HCC. Methods: From the July 2000 to July 2006, 144 patients underwent hepatic resection for HCC at a single institution. After excluding those with ruptured HCC, combined or mixed HCC, and who died during admission, 116 patients were analyzed. Patients with ER (defined as within 1 year) were compared with those who remained free of disease for more than 1 year. Various clinical characteristics including tumor and operative factors were evaluated to determine the factors predicting postoperative ER using univariate and multivariate analyses. Results: ER occurred in 51 patients (44%). In the univariate analysis, tumor size (P=0.001), microvascular invasion (P=0.003), portal vein invasion (P=0.001), TNM stage (P=0.010), serum levels of alpha-fetoprotein (AFP) (P=0.002) and aspartate aminotransferase (AST) (P=0.011), and operative time (P=0.033) were significantly associated with ER. AFP and AST were the independent predictors of ER in the multivariate analysis (P<0.05). Conclusions: Preoperative serum AFP and AST levels were the independent risk factors for ER after surgical resection for HCC. Close postoperative surveillance is recommended for early detection of recurrence and additional treatments in patients with these factors.

Abstract

Background/Aims: Early recurrence (ER) after liver resection is one of the most important factors impacting the prognosis and survival of patients with hepatocellular carcinoma (HCC). This study aimed to identify the factors associated with ER after curative hepatic resection for HCC. Methods: From the July 2000 to July 2006, 144 patients underwent hepatic resection for HCC at a single institution. After excluding those with ruptured HCC, combined or mixed HCC, and who died during admission, 116 patients were analyzed. Patients with ER (defined as within 1 year) were compared with those who remained free of disease for more than 1 year. Various clinical characteristics including tumor and operative factors were evaluated to determine the factors predicting postoperative ER using univariate and multivariate analyses. Results: ER occurred in 51 patients (44%). In the univariate analysis, tumor size (P=0.001), microvascular invasion (P=0.003), portal vein invasion (P=0.001), TNM stage (P=0.010), serum levels of alpha-fetoprotein (AFP) (P=0.002) and aspartate aminotransferase (AST) (P=0.011), and operative time (P=0.033) were significantly associated with ER. AFP and AST were the independent predictors of ER in the multivariate analysis (P<0.05). Conclusions: Preoperative serum AFP and AST levels were the independent risk factors for ER after surgical resection for HCC. Close postoperative surveillance is recommended for early detection of recurrence and additional treatments in patients with these factors.

참고문헌 (34)

  1. Bosch FX, "Epidemiology of hepatocellular carcinoma", Clin Liver Dis, 9, pp.191~211 (2005)
  2. Cormier JN, "Management of hepatocellular carcinoma", J Gastrointest Surg, 10, pp.761~780 (2006)
  3. Poon RT, "Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome", Liver Transpl, 10(Suppl 2), pp.39~45 (2004)
  4. Regimbeau JM, "Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: Results of a multicenter study", J Surg Oncol, 85, pp.36~41 (2004)
  5. Shah SA, "Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes", J Am Coll Surg, 202, pp.275~283 (2006)
  6. Tung-Ping Poon R, "Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma", Ann Surg, 232, pp.10~24 (2000)
  7. Imamura H, "Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy", J Hepatol, 38, pp.200~207 (2003)
  8. Imamura H, "Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma", Br J Surg, 86, pp.1032~1038 (1999)
  9. Tsuda H, "Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin", Cancer Res, 52, pp.1504~1509 (1992)
  10. Hsu HC, "Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules", Hepatology, 13, pp.923~928 (1991)
  11. Ou DP, "Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV", World J Gastroenterol, 11, pp.2061~2066 (2005)
  12. Lo CM, "A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma", Ann Surg, 245, pp.831~842 (2007)
  13. Miyagawa S, "Criteria for safe hepatic resection", Am J Surg, 169, pp.589~594 (1995)
  14. Lee SY, "Outcomes of hepatic resection using intermittent hepatic vascular inflow occlusion with low central venous pressure", Korean J Hepatobiliary Pancreat Surg, 8, pp.98~104 (2004)
  15. Ikeda Y, "Early recurrence after surgery of hepatocellular carcinoma", Hepatogastroenterology, 42, pp.469~472 (1995)
  16. Ozawa K, "Experience with 225 hepatic resections for hepatocellular carcinoma over a 4-year period", Am J Surg, 161, pp.677~682 (1991)
  17. Nagorney DM, "Primary hepatic malignancy: surgical management and determinants of survival", Surgery, 106, pp.740~748 (1989)
  18. Ercolani G, "Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence", Ann Surg, 237, pp.536~543 (2003)
  19. Choi JH, "Risk factors of early recurrence after curative hepatic resection for hepatocellular carcinoma", J Korean Cancer Assoc, 31, pp.165~172 (1999)
  20. Kim BW, "Risk factors for immediate postoperative fatal recurrence of hepatocellular carcinoma", Korean J Hepatobiliary Pancreat Surg, 9, pp.36~43 (2005)
  21. Lai EC, "The pathological basis of resection margin for hepatocellular carcinoma", World J Surg, 17, pp.786~790 (1993)
  22. Park JH, "Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma", Am J Surg, 192, pp.29~33 (2006)
  23. Shi M, "Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial", Ann Surg, 245, pp.36~43 (2007)
  24. Poon RT, "Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal", Ann Surg, 231, pp.544~551 (2000)
  25. Hasegawa K, "Prognostic impact of anatomic resection for hepatocellular carcinoma", Ann Surg, 242, pp.252~259 (2005)
  26. Portolani N, "Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications", Ann Surg, 243, pp.229~235 (2006)
  27. Yeung YP, "Natural history of untreated nonsurgical hepatocellular carcinoma", Am J Gastroenterol, 100, pp.1995~2004 (2005)
  28. Peng SY, "High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations", Int J Cancer, 112, pp.44~50 (2004)
  29. Kim JC, "Clinical features of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels in Korean patients", Korean J Hepatol, 5, pp.322~331 (1999)
  30. Pang RW, "Biology of hepatocellular carcinoma", Ann Surg Oncol, 15, pp.962~971 (2008)
  31. Fuke H, "Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization", Aliment Pharmacol Ther, 27, pp.1253~1260 (2008)
  32. Changchien CS, "Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival", J Gastroenterol, 43, pp.159~170 (2008)
  33. Kew MC, "Serum aminotransferase concentration as evidence of hepatocellular damage", Lancet, 355, pp.591~592 (2000)
  34. Boyde TR, "Detection and assay of mitochondrial aspartate aminotransferase in serum", Z Klin Chem Klin Biochem, 6, pp.431~435 (1968)

관련 논문AI추천

수술 전 알파태아단백치가 높은 간세포암 환자에서 간절제술 후 알파태아단백만을 이용한 추적관찰이 가능한가?김태훈, 서경석, 신우영, 이건욱, 이남준, 전영민대한간학회 · Clinical and Molecular Hepatology2010 · 제16권 제2호Preoperative Radiologic and Postoperative Pathologic Risk Factors for Early Intra-Hepatic Recurrence in Hepatocellular Carcinoma Patients Who Underwent Curative Resection김경식, 김기황, 김명진, 김한솔, 김현기, 박미숙, 박영년, 안상훈, 최진섭, 한광협연세대학교의과대학 · Yonsei Medical Journal2009 · 제50권 제6호Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy서경석, 이경분, 이규호, 이남준, 장자준대한병리학회 · Journal of Pathology and Translational Medicine2017 · 제51권 제1호B형간염과 연관된 간세포암종의 근치적 절제술 후 혈관내피성장인자 아형의 발현양상 및 예후와의 관계권준혁, 김성주, 김종만, 문주익, 박재범, 정금오, 조재원, 천재민, 최규성대한간학회 · Clinical and Molecular Hepatology2008 · 제14권 제2호간세포암종에서 간절제술 후 이환율과 사망률에 영향을 미치는 위험 인자고광철, 김성주, 김완욱, 김용일, 백승운, 유병철, 이광웅, 이대성, 이준혁, 이환효, 조재원, 최문석, 최성호, 허진석대한간학회 · Clinical and Molecular Hepatology2004 · 제10권 제2004호Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience최훈, 강하얀, 권병운, 김배환, 김용현, 김형준, 송일한, 신현덕, 신현성, 이상석, 이수진, 이준혁, 이현석, 한진형, 현경희대한간학회 · Clinical and Molecular Hepatology2012 · 제18권 제1호

이 간행물의 다른 논문 (8건)

우리나라 만성 C형간염 환자에서 페그인터페론과 리바비린의 병합치료에 대한 효과박은택, 이상혁, 최바울, 김지현, 박성재, 이연재, 정은욱, 박상원, 강명주, 설상영pp. 318-330위정맥류의 자연경과와 출혈의 위험인자이춘영, 신동현, 백승운, 고광철, 최용성, 이준혁, 유병철, 최문석, 이충현, 곽금연pp. 331-341간경변증 환자에서 식도정맥류 예측에 대한 간 섬유스캔의 유용성권오상, 구양서, 김유경, 최덕주, 김주현, 김연수, 정혁상pp. 342-350선택적 cyclooxygenase-2 억제제에 의한 간암세포의 성장억제에서 survivin 유전자 발현의 하향조절윤세영, 김석배, 신기철, 신정은, 신현덕, 김홍자, 김은영, 김동우, 송일한pp. 351-359다발성 폐전이를 동반한 진행성 간세포암종 환자에서 전신항암화학요법의 치료성적윤기태, 한광협, 김도영, 백용한, 이관식, 안상훈, 박준용, 최종원, 전재윤pp. 360-370
원문 보기